Patients, particularly with prostate cancer, have higher expression of TMPRSS2 as compared to patients with renal, lung, colorectal, or pancreatic cancers, while other cancers have no significant expression of TMPRSS2. This evidence concerns the gene TMPRSS2 and prostate cancer.